Cargando…
The prophylaxis and treatment potential of supplements for COVID-19
The global impact of the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infection that caused COVID-19 has been evident in the last few months from the unprecedented socioeconomic disruption to more than 600,000 deaths. The lack of vaccine and effective therapeutic ag...
Autores principales: | Sahebnasagh, Adeleh, Saghafi, Fatemeh, Avan, Razieh, Khoshi, Amirhosein, Khataminia, Masoud, Safdari, Mohammadreza, Habtemariam, Solomon, Ghaleno, Hassan Rezai, Nabavi, Seyed Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462519/ https://www.ncbi.nlm.nih.gov/pubmed/32882216 http://dx.doi.org/10.1016/j.ejphar.2020.173530 |
Ejemplares similares
-
Pharmacological treatments of COVID-19
por: Sahebnasagh, Adeleh, et al.
Publicado: (2020) -
A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19
por: Sahebnasagh, Adeleh, et al.
Publicado: (2020) -
Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases
por: Sahebnasagh, Adeleh, et al.
Publicado: (2022) -
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?
por: Dowran, Razieh, et al.
Publicado: (2020) -
Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients
por: Sahebnasagh, Adeleh, et al.
Publicado: (2021)